Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,214 | 16,473 | 11,918 | 7,638 | 3,534 |
| Depreciation Amortization | 1,764 | 7,082 | 5,330 | 3,585 | 1,809 |
| Income taxes - deferred | -3 | -401 | -409 | -286 | -144 |
| Accounts receivable | 1,789 | -511 | -1,059 | 102 | -578 |
| Accounts payable and accrued liabilities | -193 | 464 | 540 | 64 | 695 |
| Other Working Capital | 887 | -2,226 | -1,514 | -1,168 | -204 |
| Other Operating Activity | -1,543 | 266 | 661 | -57 | -66 |
| Operating Cash Flow | $6,915 | $21,147 | $15,467 | $9,878 | $5,046 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -43 | -809 | -771 | -450 | -237 |
| Purchase Sale Intangibles | N/A | -9 | -9 | -9 | N/A |
| Other Investing Activity | 0 | -9 | -9 | -9 | 0 |
| Investing Cash Flow | $-43 | $-818 | $-780 | $-459 | $-237 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 21 | 174 | 43 | 23 | 19 |
| Common Stock Repurchased | N/A | -2,495 | -2,495 | -2,495 | N/A |
| Dividend Paid | -1,070 | -3,163 | -2,112 | -1,060 | N/A |
| Financing Cash Flow | $-1,049 | $-5,484 | $-4,564 | $-3,532 | $19 |
| Exchange Rate Effect | 37 | -767 | -1,586 | -637 | 71 |
| Beginning Cash Position | 75,052 | 60,974 | 60,974 | 60,974 | 60,974 |
| End Cash Position | 80,912 | 75,052 | 69,511 | 66,224 | 65,873 |
| Net Cash Flow | $5,860 | $14,078 | $8,537 | $5,250 | $4,899 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,915 | 21,147 | 15,467 | 9,878 | 5,046 |
| Capital Expenditure | -43 | -809 | -771 | -450 | -237 |
| Free Cash Flow | 6,872 | 20,338 | 14,696 | 9,428 | 4,809 |